Difference between revisions of "Template:Drugs for peptic ulcer and GORD"
Jump to navigation
Jump to search
(fix redirect, clarify acronyms) |
imported>Alex Nico (Undid revision 948183052 by 78.32.143.113 (talk) Why eliminate the upper case words?? The other templates use them...) |
||
Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
− | |name = Drugs for peptic ulcer and GORD | + | | name = Drugs for peptic ulcer and GORD |
− | |title= | + | | title = Drugs for [[peptic ulcer]] and [[Gastroesophageal reflux disease|GERD/GORD]] ([[ATC_code_A02#A02B|A02B]]) |
− | |listclass= hlist | + | | state = {{{state|autocollapse}}} |
+ | |listclass = hlist | ||
− | |group1= [[H2 antagonist|H<sub>2</sub> antagonists]] ( | + | | group1 = [[H2 antagonist|H<sub>2</sub> antagonists]] ("-tidine") |
− | |list1= | + | | list1 = |
− | *[[Cimetidine]] | + | * [[Cimetidine]] |
− | *[[Famotidine]] | + | * [[Famotidine]] |
− | *[[Lafutidine]] | + | * [[Lafutidine]] |
− | *[[Lavoltidine|Lavoltidine (loxtidine)]] | + | * [[Lavoltidine|Lavoltidine (loxtidine)]] |
− | *[[Niperotidine]] | + | * [[Niperotidine]] |
− | *[[Nizatidine]] | + | * [[Nizatidine]] |
− | *[[Ranitidine]]<sup>#</sup> | + | * [[Ranitidine]]<sup>#</sup> |
− | *[[Roxatidine acetate|Roxatidine]] | + | * [[Roxatidine acetate|Roxatidine]] |
− | |group2= [[ | + | | group2 = [[Prostaglandin]]s (E)/[[Prostaglandin analogue|analogue]]s ("-prost-") |
− | |list2= | + | | list2 = |
− | *[[Misoprostol]] | + | * [[Misoprostol]] |
− | *[[Enprostil]] | + | * [[Enprostil]] |
− | |group3= [[Proton-pump inhibitor | + | | group3 = [[Proton-pump inhibitor]]s ("-prazole") |
− | |list3= | + | | list3 = |
− | *[[Azeloprazole]] | + | * [[Azeloprazole]] |
− | *[[Dexlansoprazole]] | + | * [[Dexlansoprazole]] |
− | *[[Esomeprazole]] | + | * [[Esomeprazole]] |
− | *[[Ilaprazole]] | + | * [[Ilaprazole]] |
− | *[[Lansoprazole]] | + | * [[Lansoprazole]] |
− | *[[Omeprazole]]<sup>#</sup> | + | * [[Omeprazole]]<sup>#</sup> |
− | *[[Pantoprazole]] | + | * [[Pantoprazole]] |
*[[Picoprazole]] | *[[Picoprazole]] | ||
− | *[[Rabeprazole]] | + | * [[Rabeprazole]] |
− | *[[Tenatoprazole]] | + | * [[Tenatoprazole]] |
*[[Timoprazole]] | *[[Timoprazole]] | ||
− | |group4= | + | | group4 = Potassium-competitive acid blockers ("-prazan") |
− | |list4= | + | | list4 = |
− | *[[Linaprazan]] | + | * [[Linaprazan]] |
− | *[[Revaprazan]] | + | * [[Revaprazan]] |
− | *[[Soraprazan]] | + | * [[Soraprazan]] |
− | *[[Vonoprazan]] | + | * [[Vonoprazan]] |
− | |group5= | + | | group5 = Others |
− | |list5= | + | | list5 = |
− | *[[Aceglutamide aluminum]] | + | * [[Aceglutamide aluminum]] |
− | *[[Acetoxolone]] | + | * [[Acetoxolone]] |
− | *[[Alginic acid]] | + | * [[Alginic acid]] |
− | *[[Arbaclofen placarbil]] | + | * [[Arbaclofen placarbil]] |
− | *[[Bismuth subcitrate]] | + | * [[Bismuth subcitrate]] |
− | *[[Carbenoxolone]] | + | * [[Carbenoxolone]] |
− | *[[Cetraxate]] | + | * [[Cetraxate]] |
− | *[[Gefarnate]] | + | * [[Gefarnate]] |
− | *[[Lesogaberan]] | + | * [[Lesogaberan]] |
− | *[[Pirenzepine]] | + | * [[Pirenzepine]] |
− | *[[Proglumide]] | + | * [[Proglumide]] |
− | *[[Rebamipide]] | + | * [[Rebamipide]] |
− | *[[Sucralfate]] | + | * [[Sucralfate]] |
− | *[[Sulglicotide]] | + | * [[Sulglicotide]] |
− | *[[Telenzepine]] | + | * [[Telenzepine]] |
− | *[[Teprenone]] | + | * [[Teprenone]] |
− | *[[Troxipide]] | + | * [[Troxipide]] |
− | *[[Zinc L-carnosine]] | + | * [[Zinc L-carnosine]] |
− | *[[Zolimidine]] | + | * [[Zolimidine]] |
− | |group6= | + | | group6 = Combinations |
− | |list6= | + | | list6 = |
− | *[[Bismuth subcitrate/metronidazole/tetracycline]] | + | * [[Bismuth subcitrate/metronidazole/tetracycline]] |
+ | |||
+ | | list7 = | ||
+ | * ''See also: [[Helicobacter pylori eradication protocols|''Helicobacter pylori'' eradication protocols]]'' | ||
+ | |||
+ | | belowstyle = background: transparent; padding: 0px; | ||
+ | | below = {{PharmNavFootnote}} | ||
− | |||
− | |||
− | |||
− | |||
}}<noinclude> | }}<noinclude> | ||
− | {{ | + | {{collapsible option}} |
[[Category:Drugs for acid-related disorders]] | [[Category:Drugs for acid-related disorders]] | ||
− | [[Category:Drug templates by ATC]]</noinclude> | + | [[Category:Drug templates by ATC]] |
+ | |||
+ | </noinclude> |
Latest revision as of 14:59, 14 May 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Drugs for peptic ulcer and GORD|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Drugs for peptic ulcer and GORD|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Drugs for peptic ulcer and GORD|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.